Docmode Health Tech Ltd Stock Price Today (NSE: DHTL)

Docmode Health Tech Ltd

33.85+3.20 (+10.44%)
Market Closed

Fundamental Score

...

Docmode Health Tech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Docmode Health Tech Ltd share price today is 33.85, up +10.44% on NSE/BSE as of 7 August 2026. Docmode Health Tech Ltd (DHTL) is a Small-cap company in the E-Learning sector with a market capitalisation of 12.14 (Cr). The 52-week high for DHTL share price is 120.75 and the 52-week low is 32.25. The company has a Return on Equity (ROE) of -21.69% and a debt-to-equity ratio of 0.90.

Docmode Health Tech Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
39.35
Low
33.85
Volume
3.2K
Change
-8.00%

Docmode Health Tech Ltd share price chart: -8.00% return over the past month. 52-week high ₹120.75, 52-week low ₹32.25.

Docmode Health Tech Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
30.6533.8530.6533.857.20K (Cr)
32.2532.2532.2532.251.60K (Cr)
33.9033.9033.9033.901.60K (Cr)
35.6539.3535.6535.654.00K (Cr)
37.5037.5037.5037.50800.00 (Cr)
36.7537.9536.7037.508.00K (Cr)
35.0038.6035.0038.602.40K (Cr)
36.8536.8536.8536.851.60K (Cr)
39.0039.0038.7538.752.40K (Cr)
48.4548.4548.4548.451.60K (Cr)

Docmode Health Tech Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
33.9033.9030.6533.85-0.15%
39.0039.3535.0035.65-8.59%
46.3048.6044.5048.45+4.64%
44.1044.1044.1044.10+0.00%
40.0040.5040.0040.50+1.25%
65.9068.4546.9046.90-28.83%
72.8072.8064.6564.65-11.20%
89.1089.2055.8571.30-19.98%
114.35120.75104.45115.00+0.57%
78.80119.6078.80118.00+49.75%
43.0571.5536.9071.55+66.20%
50.6051.6046.0046.00-9.09%

AI Research Briefing

Powered by Gemini · 2026-08-01

Avoid this micro-cap trap with delayed financial filings, pledged promoter equity, and broken interest coverage.

Research Confidence
3.0/10Low
MICRO-CAP DARK HORSESevere breakdown — down 41.47% over 6 months and near 52-week lows.Expensive/Distressed — negative P/E with severe earnings losses against industry P/E of 36.04x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major commercial order catalysts found after live search. Operational chaos rules the desk: the company missed its statutory May 30, 2026 deadline to submit audited financial results, citing key personnel emergency leave. An Extraordinary General Meeting was rescheduled to July 8, 2026, seeking shareholder approval to change the corporate name to Doctrack Solutions Limited alongside fresh auditor appointments.

CORE STORY (THE REAL GAME)

A micro-cap healthcare e-learning proxy that promised high-margin pharma CME platforms but delivered severe operational friction, net losses, and balance sheet stress. The market treats this as a distressed micro-cap attempt at corporate rebranding rather than a scalably profitable med-tech play.

Why Now
  • Delayed statutory filing of audited FY26 financial results past the May 30, 2026 SEBI deadline
  • Rescheduled EGM to July 8, 2026 to push through a corporate name change to Doctrack Solutions Limited
  • Deteriorating FY25 financials reporting net loss of ₹-2.03 Cr on sales of ₹41.77 Cr
Potential Catalysts
  • Submission and release of audited financial results showing operational turnaround
  • Inbound large pharma CME contract wins or commercial partnerships
  • Revocation of pledged promoter shares
Key Risks
  • Severe liquidity risk in micro-cap basket with market cap of ₹12.14 Cr
  • High promoter pledge at 37.37% combined with declining promoter stake (-1.37%)
  • Critically low interest coverage ratio of 0.08x and 5-year FCF of ₹-5.27 Cr
Institutional Activity

Zero FII and DII participation (0.0%), while promoter stake declined 1.37% to 29.49% with 37.37% pledged.

Macro Context

Digital e-learning adoption in India is expanding, but niche CME players lack scale against broader platforms.

Order Book / Expansion

No major news found after live search.

Cash Flow Quality

Negative — fail converting profit to cash with 5-year FCF at ₹-5.27 Cr.

3–6 Month Outlook

High risk of continued underperformance and debt distress over 3-6 months. Execution visibility remains severely impaired.

Primary Thesis Risk

Audit compliance failure combined with debt service insolvency.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

-21.69%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

-0.29%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

5.74%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Docmode Health Tech Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

36.04x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

29.49%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

37.37%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

82.69%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-12.59%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

43.14%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.90x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

0.08x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-5.27 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Docmode Health Tech Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of DHTL across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Robust Profit Growth (82.69%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Consistent Growth Track Record (43.14% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Risk Factors

8 factors identified

Below-Average Return on Equity (-21.69%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (-0.29%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Revenue Contraction (-12.59%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Weak Interest Coverage (0.08x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-5.27 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (29.49%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

High Share Pledging Risk (37.37%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Docmode Health Tech Ltd vs E-Learning Peers

Peer Comparison - E-Learning

Compare Docmode Health Tech Ltd with 7 other companies in the same sector

8 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
0/100
34
₹12.14
-21.69%
Poor
-0.29%
Poor
0.9
Good
43.14%
Excellent
0.00%
Mps Limited...
MPSLTD532440
65.7/100
2696
₹3426.65
20.5
Average
31.16%
Excellent
39.27%
Excellent
0.1
Excellent
23.74%
Excellent
12.70%
Good
4.14%
35.1/100
259
₹2206.12
46.8
Average
7.75%
Poor
12.79%
Average
0.4
Excellent
50.37%
Excellent
185.47%
Excellent
0.00%
52.6/100
110
₹197.76
22.7
Average
13.08%
Average
25.13%
Excellent
0.0
Excellent
294.13%
Excellent
96.68%
Excellent
0.00%
57.8/100
142
₹96.82
27.9
Average
22.37%
Excellent
26.62%
Excellent
0.0
Excellent
145.26%
Excellent
89.34%
Excellent
0.29%
17/100
99
₹61.26
-2.18%
Poor
-1.42%
Poor
0.0
Excellent
22.48%
Excellent
0.00%
21.8/100
28
₹26.50
-82.87%
Poor
-36.32%
Poor
2.4
Poor
12.38%
Good
45.14%
Excellent
0.00%
50.4/100
5
₹15.21
37.1
Average
4.81%
Poor
5.23%
Poor
0.1
Excellent
68.71%
Excellent
8.32%
Good
0.00%

Docmode Health Tech Ltd Quarterly Performance

Latest quarterly metrics for DHTL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-12.59%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

82.69%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

43.14%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Docmode Health Tech Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for DHTL — calculated from daily price history

24RSI 14
Oversold — RSI 24

Selling pressure is heavy — potential reversal zone.

SMA 50
70
▼ Price below SMA 50 — Short-term bearish
SMA 200
61
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
2K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Docmode Health Tech Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Docmode Health Tech Ltd (DHTL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Docmode Health Tech Ltd

About DHTL (Docmode Health Tech Ltd)

Docmode Health Tech Ltd (DHTL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the E-Learning sector with a current... market capitalisation of ₹12.14 (Cr). Docmode Health Tech Ltd has delivered a Return on Equity (ROE) of -21.69% and a ROCE of -0.29%. The debt-to-equity ratio stands at 0.90, reflecting the company's capital structure. Investors tracking DHTL share price can monitor key metrics including P/E ratio, promoter holding of 29.49%, and quarterly earnings growth.

Company Details

Symbol:DHTL
Industry:E-Learning
Sector:E-Learning
Website:N/A

DHTL Share Price: Frequently Asked Questions

What is the current share price of Docmode Health Tech Ltd?

Docmode Health Tech Ltd (DHTL) trades at ₹33.85 on NSE. Market cap ₹12.14 (Cr). Educational data only.

What is the P/E ratio of Docmode Health Tech Ltd?

Docmode Health Tech Ltd has a P/E of N/Ax vs industry average 36.04x.

What is the Bull Run score for Docmode Health Tech Ltd?

Docmode Health Tech Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.

Does Docmode Health Tech Ltd pay dividends?

Docmode Health Tech Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Docmode Health Tech Ltd?

Docmode Health Tech Ltd has ROE of -21.69%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Docmode Health Tech Ltd?

Docmode Health Tech Ltd has debt-to-equity of 0.90.

Is Docmode Health Tech Ltd a good investment?

Bull Run gives Docmode Health Tech Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.